Detalhe da pesquisa
1.
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasma.
Ann Oncol
; 33(8): 794-803, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35491007
2.
Integrating postradiotherapy plasma Epstein-Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy.
Ann Oncol
; 31(6): 769-779, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217076
3.
The Use of Post-ablation Stimulated Thyroglobulin in Predicting Clinical Outcomes in Differentiated Thyroid Carcinoma - What Cut-off Values Should We Use?
Clin Oncol (R Coll Radiol)
; 31(2): e11-e20, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30454940
4.
Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
Clin Oncol (R Coll Radiol)
; 25(12): 706-12, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23954261